Optilite IgM Kit— 510(k) K191635

Substantially Equivalent

The Binding Site Group , Ltd.

FDA 510(k) clearance K191635 for Optilite IgM Kit, Substantially Equivalent on 2019-07-15. Applicant: The Binding Site Group , Ltd.. Device class: 2.

Clearance details

Applicant: The Binding Site Group , Ltd.
Product code: Code CFN
Device class: Class 2
Regulation: 21 CFR 866.5510
Advisory panel: Immunology
Date received: 2019-06-19
Decision date: 2019-07-15
Decision: Substantially Equivalent
Clearance type: Special
Location: Edgbaston, GB

Download summary PDF View on FDA.gov ↗

Recent devices under product code CFN

K233663 — N Antisera to Human Immunoglobulins (IgG, IgA, and IgM)2023-12-13
K221114 — Immunoglobulin G (IgG)2023-08-02
K192116 — Human IgA liquid reagent kit for Use on SPAPlus2019-09-04
K191985 — Optilite IgA Kit2019-08-19
K191465 — Human IgM Kit for use on SPAPlus2019-06-27

More clearances from The Binding Site Group , Ltd.

K250159 — Immunoglobulin Isotypes (GAM) for the EXENT Analyser; EXENT Analyser2025-10-17
K250549 — Optilite® Freelite Mx Kappa Free Kit; Optilite® Freelite Mx Lambda Free Kit2025-05-23
K190686 — Optilite IgM CSF Kit2019-05-28
K183151 — Optilite IgA CSF Kit2019-01-23
K180099 — Optilite High Sensitivity C-Reactive Protein Kit2018-10-12

Recalls naming K191635

K-number listed on FDA's recall record

Z-1327-2020 — OPTILITE IgM Kit, REF: NK012.OPT.A, IVD, UDI: 05051700017565Class II·Terminated·The Binding Site Group, Ltd.·20190729

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K191635.

Data sourced from openFDA. This site is unofficial and independent of the FDA.